Infliximab for the treatment of early rheumatoid arthritis

Author： Geletka Robin C   St Clair E William  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.5, Iss.3, 2005-03, pp. : 405-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab in the treatment of rheumatoid arthritis

By Voulgari Paraskevi V   Kaltsonoudis Evripidis   Papagoras Charalampos   Drosos Alexandros A  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1679-1686

Informa Healthcare

Access to resources Recommend Favorite

Etanercept in the treatment of rheumatoid arthritis

By Hunt Laura   Emery Paul  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 10, 2013-10 ,pp. : 1441-1450

Informa Healthcare

Access to resources Recommend Favorite

Cytokine inhibitors in the treatment of rheumatoid arthritis

By Gabay Cem  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 135-149

Informa Healthcare

Access to resources Recommend Favorite

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis

By Fleischmann Roy   Stern Richard   Iqbal Imran  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 8, 2004-08 ,pp. : 1333-1344

Informa Healthcare

Access to resources Recommend Favorite

Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis

By Teng Gim Gee   Turkiewicz Anthony M   Moreland Larry W  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 9, 2005-09 ,pp. : 1245-1254

Informa Healthcare

Access to resources Recommend Favorite